VRTX
Vertex Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
VRTX fundamentals
Vertex Pharmaceuticals (VRTX) Revenue Breakdown: Q4 2025 Business & Regional Performance
Vertex Pharmaceuticals (VRTX) reported total revenue of 3.19B USD in Q4 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 64.24% of total revenue. Explore Vertex Pharmaceuticals's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Vertex Pharmaceuticals (VRTX) reported total revenue of 3.19B USD in Q4 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 64.24% of total revenue. Explore Vertex Pharmaceuticals's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for Vertex Pharmaceuticals year over year?What were the key takeaways from Vertex Pharmaceuticals's earnings call?Did Vertex Pharmaceuticals beat or miss consensus estimates last quarter?What factors drove the changes in Vertex Pharmaceuticals's revenue and profit?What does Vertex Pharmaceuticals do and what are its main business segments?What guidance did Vertex Pharmaceuticals's management provide for the next earnings period?What is Vertex Pharmaceuticals's latest dividend and current dividend yield?What is Vertex Pharmaceuticals's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
